|
Publications Related
to FAST-MAG Trial
by FAST-MAG Investigators
FAST-MAG Pilot
Trial
Saver JL, Kidwell C, Eckstein M,
Ovbiagele B, Starkman S, for the FAST-MAG Pilot Trial
Investigators. Physician-investigator phone elicitation of
consent in the field: a novel method to obtain explicit
informed consent for prehospital clinical research.
Prehospital Emergency Care 2006;10:182-5.
Saver JL, Kidwell C, Eckstein M,
Starkman S, for the FAST-MAG Pilot Trial Investigators.
Prehospital neuroprotective therapy for acute stroke: results
of the Field Administration of Stroke Therapy – Magnesium
(FAST-MAG) Pilot Trial. Stroke 2004;35:e106-e108. (DOI:
10.1161/01.STR.0000124458.98123.52)
Saver JL, Kidwell CS, Eckstein M, Starkman S, FAST-MAG Pilot
Trial Investigators. High accuracy of LAPSS-guided paramedic
selection of stroke patients for field-delivery of
neuroprotective therapy. Stroke 2003;34:279A.
Los Angeles Prehospital Stroke Screen
Saver JL, Kidwell CS, Eckstein M, Starkman S. Emerging
applications of the Los Angeles Prehospital Stroke Screen (LAPSS),
a validated tool for prehospital stroke recognition. The
Stroke Interventionalist 2001;2(3):6-7.
Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL.
Identifying stroke in the field: prospective validation of the
Los Angeles Prehospital Stroke Screen (LAPSS). Stroke
2000;31:71-76.
Kidwell CS, Saver JL, Schubert GB, Eckstein M, Starkman S.
Design and retrospective analysis of the Los Angeles
Prehospital Stroke Screen (LAPSS). Prehospital Emergency Care
1998;2:267-273.
Los Angeles Motor Scale
Llanes JN, Kidwell CS, Starkman S, Leary MC, Eckstein M, Saver
JL. The Los Angeles Motor Scale (LAMS): A new measure for
characterizing stroke severity in the field. Prehospital
Emergency Care 2004;8:46-50.
Ferguson KN, Kidwell CS, Starkman S, Eckstein M, Saver JL.
Inter-rater and intra-rater reliability of the Los Angeles
Motor Scale (LAMS), a prehospital measure of stroke severity.
Stroke 2002;33:384.
roprotective
agents for the treatment of acute ischemic stroke. Current
Neurology and Neuroscience Reports 2003;3:9-20.
Ferguson KN, Kidwell CS, Starkman S, Saver JL. Hyperacute
treatment initiation in neuroprotective stroke trials.
Neurology 2002;58(suppl 3):A387.
Kidwell CS, Liebeskind DS, Starkman S, Saver JL. Trends in
ischemic stroke trials through the 20th century. Stroke
2001;32:1349-1359.
Liebeskind DS, Kidwell CS, Saver JL. Meta-analysis of acute
stroke trials employing neuroprotective agents. Neurology
1998;50:A346.
Publications from the FAST-MAG Phase 3 Trial Award
Stewart D, Marder VJ,
Starkman S, Saver JL. Magnesium sulfate neither potentiates
nor inhibits tissue plasminogen activator induced
thrombolysis. J Thromb Haemost 2006; 4: 1575–9.
Saver JL. Time is brain--quantified. Stroke
2006;37:263-6.
|
